— Know what they know.
Not Investment Advice

RGC NASDAQ

Regencell Bioscience Holdings Limited
1W: +2.5% 1M: -3.9% 3M: -15.4% YTD: +31.4% 1Y: +161.1% 3Y: +3564.3%
$27.00
-0.79 (-2.84%)
Pre-Market: $27.62 (+0.62, +2.30%)
Weekly Expected Move ±11.1%
$22 $25 $29 $32 $35
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 47 · $13.4B mcap · 17M float · 0.780% daily turnover · Short 53% of daily vol
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$13.4B
52W Range8.70395-83.6
Volume96,866
Avg Volume134,519
Beta1.87
Dividend
Analyst Ratings
0 Buy 4 Hold 0 Sell
Consensus Hold
Company Info
CEOYat-Gai Au
Employees12
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2021-07-16
First Commercial Building
Causeway Bay KY1-1107
HK
852 2155 0823
About Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Recent Insider Trades

NameTypeSharesPriceDate
LO MARGARET HOOR HAN 0 2026-03-18
AU YAT-PUI 0 2026-03-18
AU YAT-GAI 0 2026-03-18
LO WILLIAM WING YAN 592,230 $0.84 2026-03-18
ANSCHUTZ PHILIP F D-Return 12,440,000 $23.00 2018-02-28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms